Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Extracellular vesicles from IFN-γ-primed mesenchymal stem cells repress atopic dermatitis in mice.

< BACK TO ARCHIVE


Papers: 10 Dec 2022 - 16 Dec 2022


Animal Studies


2022 Dec 10


J Nanobiotechnology


http://www.ncbi.nlm.nih.gov/pubmed/36496385?dopt=Abstract


20


1

Extracellular vesicles from IFN-γ-primed mesenchymal stem cells repress atopic dermatitis in mice.

Authors

Extracellular vesicles from IFN-γ-primed mesenchymal stem cells repress atopic dermatitis in mice.
Kim J M, Lee S K, Jung M, Jeong S-Y, You H, Won J-Y, Han S-D, Cho H J, Park S, Park J, Kim T, Kim S
J Nanobiotechnology. 2022 Dec 10; 20(1):526.
PMID: 36496385.

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by immune dysregulation, pruritus, and abnormal epidermal barrier function. Compared with conventional mesenchymal stem cell (MSC), induced pluripotent stem cell (iPSC)-derived mesenchymal stem cell (iMSC) is recognized as a unique source for producing extracellular vesicles (EVs) because it can be obtained in a scalable manner with an enhanced homogeneity. Stimulation of iMSCs with inflammatory cytokines can improve the immune-regulatory, anti-inflammatory, and tissue-repairing potential of iMSC-derived EVs.
Read This Paper